Helicobacter pylori in gastrointestinal manifestation of systemic sclerosis

J. Raja, Shanthini Muthusamy, Choung Min Ng, S. Mahadeva
{"title":"Helicobacter pylori in gastrointestinal manifestation of systemic sclerosis","authors":"J. Raja, Shanthini Muthusamy, Choung Min Ng, S. Mahadeva","doi":"10.1177/23971983241227133","DOIUrl":null,"url":null,"abstract":"To study the prevalence of Helicobacter pylori in systemic sclerosis patients and its gastrointestinal manifestations in comparison with Helicobacter pylori-negative systemic sclerosis patients. Systemic sclerosis gastrointestinal outcome post Helicobacter pylori eradication was evaluated. In total, 70 systemic sclerosis patients and 70 age-, gender- and race-matched healthy controls had their urea breath test done. Gastrointestinal manifestations in systemic sclerosis were assessed using University of California at Los Angeles 2.0 and Leeds Dyspepsia Questionnaire questionnaires. Systemic sclerosis patients with confirmed Helicobacter pylori infection were given standard Helicobacter pylori eradication therapy. Urea breath test was repeated 6 weeks posteradication therapy with their gastrointestinal symptoms reassessed. The prevalence of Helicobacter pylori was low in both systemic sclerosis patients (10%) and healthy controls (2.9%). There was no significant difference in gastrointestinal symptoms between Helicobacter pylori-positive and Helicobacter pylori-negative systemic sclerosis patients. However, the Helicobacter pylori-positive patients reported higher median severity scores for the gastrointestinal symptoms of reflux (0.5 vs 0.35), abdominal distension (1.5 vs 0.75) and social functioning impairment score (0.5 vs 0.16) using the University of California at Los Angeles 2.0 score. The Helicobacter pylori-positive patients also indicated increased upper abdominal pain (3.0 vs 0.0), regurgitation (2.0 vs 0.0) and burping (3.0 vs 0.0), observed from the Leeds Dyspepsia Questionnaire scores. Gastrointestinal outcomes post- Helicobacter pylori eradication showed either an improvement or complete resolution of symptoms. Gastrointestinal symptoms in systemic sclerosis patients are unlikely to be caused by Helicobacter pylori in the recent years in our cohort of patients. No significant difference in gastrointestinal symptoms was seen between Helicobacter pylori-positive and Helicobacter pylori-negative systemic sclerosis patients. Helicobacter pylori can be readily tested by urea breath test to look for present infection.","PeriodicalId":506053,"journal":{"name":"Journal of Scleroderma and Related Disorders","volume":"76 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Scleroderma and Related Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/23971983241227133","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

To study the prevalence of Helicobacter pylori in systemic sclerosis patients and its gastrointestinal manifestations in comparison with Helicobacter pylori-negative systemic sclerosis patients. Systemic sclerosis gastrointestinal outcome post Helicobacter pylori eradication was evaluated. In total, 70 systemic sclerosis patients and 70 age-, gender- and race-matched healthy controls had their urea breath test done. Gastrointestinal manifestations in systemic sclerosis were assessed using University of California at Los Angeles 2.0 and Leeds Dyspepsia Questionnaire questionnaires. Systemic sclerosis patients with confirmed Helicobacter pylori infection were given standard Helicobacter pylori eradication therapy. Urea breath test was repeated 6 weeks posteradication therapy with their gastrointestinal symptoms reassessed. The prevalence of Helicobacter pylori was low in both systemic sclerosis patients (10%) and healthy controls (2.9%). There was no significant difference in gastrointestinal symptoms between Helicobacter pylori-positive and Helicobacter pylori-negative systemic sclerosis patients. However, the Helicobacter pylori-positive patients reported higher median severity scores for the gastrointestinal symptoms of reflux (0.5 vs 0.35), abdominal distension (1.5 vs 0.75) and social functioning impairment score (0.5 vs 0.16) using the University of California at Los Angeles 2.0 score. The Helicobacter pylori-positive patients also indicated increased upper abdominal pain (3.0 vs 0.0), regurgitation (2.0 vs 0.0) and burping (3.0 vs 0.0), observed from the Leeds Dyspepsia Questionnaire scores. Gastrointestinal outcomes post- Helicobacter pylori eradication showed either an improvement or complete resolution of symptoms. Gastrointestinal symptoms in systemic sclerosis patients are unlikely to be caused by Helicobacter pylori in the recent years in our cohort of patients. No significant difference in gastrointestinal symptoms was seen between Helicobacter pylori-positive and Helicobacter pylori-negative systemic sclerosis patients. Helicobacter pylori can be readily tested by urea breath test to look for present infection.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
幽门螺杆菌在系统性硬化症胃肠道表现中的作用
与幽门螺旋杆菌阴性的系统性硬化症患者相比,研究幽门螺旋杆菌在系统性硬化症患者中的感染率及其胃肠道表现。评估根除幽门螺旋杆菌后系统性硬化症患者的胃肠道表现。共有 70 名系统性硬化症患者和 70 名年龄、性别和种族匹配的健康对照者接受了尿素呼气试验。使用加利福尼亚大学洛杉矶分校 2.0 和利兹消化不良问卷评估了系统性硬化症的胃肠道表现。对确诊感染幽门螺旋杆菌的系统性硬化症患者进行了标准的幽门螺旋杆菌根除治疗。在接受根除治疗 6 周后再次进行尿素呼气试验,并重新评估他们的胃肠道症状。幽门螺旋杆菌在系统性硬化症患者(10%)和健康对照组(2.9%)中的感染率都很低。幽门螺旋杆菌阳性和幽门螺旋杆菌阴性的系统性硬化症患者在胃肠道症状方面没有明显差异。不过,幽门螺旋杆菌阳性患者的胃肠道症状反流(0.5 对 0.35)、腹胀(1.5 对 0.75)和社会功能障碍(0.5 对 0.16)的中位数严重程度评分(采用加利福尼亚大学洛杉矶分校 2.0 评分标准)较高。根据利兹消化不良问卷评分,幽门螺杆菌阳性患者的上腹部疼痛(3.0 对 0.0)、反胃(2.0 对 0.0)和打嗝(3.0 对 0.0)也有所增加。根除幽门螺杆菌后的胃肠道结果显示症状有所改善或完全消失。近年来,在我们的患者队列中,系统性硬化症患者的胃肠道症状不太可能由幽门螺旋杆菌引起。幽门螺旋杆菌阳性和幽门螺旋杆菌阴性的系统性硬化症患者在胃肠道症状方面没有明显差异。幽门螺旋杆菌可通过尿素呼气试验来检测是否存在感染。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Troponin I levels in systemic sclerosis patients with myocardial involvement Prevalence, causes, and clinical associations of anemia in patients with systemic sclerosis: A cohort study Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologists Resilience partially mediates the association between perceived social isolation and life satisfaction in people with systemic sclerosis Oral abstracts
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1